Events

World Ophthalmology Congress 2008
XXXI International Congress of Ophthalmology

Hong Kong, China
June 28 - July 2, 2008

Title: To assess the efficacy and ocular bioavailability of topically administered mecamylamine (ATG-3, MEC), a non-selective nicotinic acetylcholine receptor (nAChR) antagonist with anti-angiogenic properties in a murine model of choroidal neovascularization (CNV).

Presenter: M. (Ken) Kengatharan, Ph.D., M.B.A, Vice-President, Translational Research and Scientific Affairs, CoMentis

16th Annual BioPartnering Europe

London, UK
October 12-14, 2008

Title: Technology, Strategy, and Business Objectives of CoMentis

Presenter: Dr. Martin Tolar, M.D., Ph.D., Chief Scientific Officer, CoMentis